Medpace, Inc. Our company was established in 1992  to bring promising new drugs to market togehther with our partners with leading pharmaceutical, biotechnology, and medical device companies. As a full-service Clinical Research Organization (CRO), we combine efficient clinical trial management, comprehensive regulatory consulting, and innovative technologies to create a customized approach that ensures powerful solutions for our partners around the globe. Led by therapeutic experts with extensive experience in the advancement of pharmaceutical agents for use in multiple therapeutic specialties, our dedicated teams deliver rapid and accurate clinical trial results for the most complete Phase I-IV clinical research support in the industry. Our regulatory experts – former government officials with valuable international insight into specific areas of drug approval – are involved at project initiation, allowing them to develop an accurate description of your data to ensure that every phase of trial is precisely focused for maximum results. Regardless of project size, we have the breadth, depth, experience, and flexibility to deploy a study on six continents.